Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Eflornithine + Hydroquinone + Fluocinolone vs Tri-Luma for Melasma
NCT07876323Phase 2Completed
- Sponsor
- National Skin Centre
- Start
- Jun 2023
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
A Phase 2 trial of eflornithine in melasma, sponsored by National Skin Centre. Started Jun 2023; status: completed.
02
Drugs
eflornithine
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07876323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876323.